Bone Biologics Corp Stock Today
Bone Biologics is selling for under 20.20 as of the 21st of March 2025; that is No Change since the beginning of the trading day. The stock's lowest day price was 20.2. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 13th of October 2021 | Category Healthcare | Classification Health Care |
Valuation Profit Patterns
Check how we calculate scores
Bone Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Jeffrey Frelick | |||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||
Financial Strength
| ||||||||||||||||
Bone Biologics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bone Biologics' financial leverage. It provides some insight into what part of Bone Biologics' total assets is financed by creditors.
| ||||||||||||||||
Bone Biologics Corp (BBLGW) is traded on NASDAQ Exchange in USA. It is located in 2 Burlington Woods Drive, Burlington, MA, United States, 01803 and employs 2 people. Bone Biologics is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry.
Bone Biologics Corp has accumulated about 4.44 K in cash with (4.12 M) of positive cash flow from operations.
Check Bone Biologics Probability Of Bankruptcy
Bone Biologics Historical Income Statement
Bone Stock Against Markets
Bone Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bone Biologics stock to make a market-neutral strategy. Peer analysis of Bone Biologics could also be used in its relative valuation, which is a method of valuing Bone Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bone Biologics Corporate Executives
Elected by the shareholders, the Bone Biologics' board of directors comprises two types of representatives: Bone Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bone. The board's role is to monitor Bone Biologics' management team and ensure that shareholders' interests are well served. Bone Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bone Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shunichi Kuroda | CoFounder Board | Profile |
Additional Tools for Bone Stock Analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.